Anebulo Pharmaceuticals, Inc.
corporate_fare Company Profile
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) is a publicly traded company in the Healthcare sector. Wiseek has independently scored 6 items for ANEB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-02-12, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 10/10, with 6 rated 8 or above. Recent SEC coverage for ANEB spans 10-Q, 8-K, SC TO-I/A.
Recent high-impact activity:
- Anebulo Pharmaceuticals Reports Q2 FY2026 Results Amidst Voluntary Nasdaq Delisting and Deregistration Plans
- Anebulo Pharmaceuticals Reports Q2 Results Amidst Nasdaq Delisting Timeline
- Anebulo Pharmaceuticals to Voluntarily Delist from Nasdaq and Deregister with SEC
- Anebulo Pharmaceuticals Finalizes Tender Offer, Repurchasing Shares at Significant Premium
- Anebulo Pharmaceuticals Announces Oversubscribed Tender Offer at Significant Premium
Financial Snapshot
Short Interest & Short Volume
FINRA reported short interest of 390,808 shares in ANEB as of the October 30, 2026 settlement, unchanged from the prior period.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.